Large-scale testing (Phase 3)Ended earlyNCT00458081
What this trial is testing
Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors
Who this might be right for
ObesityMicroalbuminuriaDiabetes Mellitus, Type 2+1 more
Sanofi 174